GLP-2 Tirz refers to tirzepatide, a synthetic peptide used as a reference compound in laboratory research involving incretin receptor signaling and peptide-receptor interactions.
Tirzepatide is characterized by activity at two distinct receptor systems: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Although “GLP-2 Tirz” is used as the product designation, the compound is scientifically described as a dual GIP and GLP-1 receptor agonist.
Its defined molecular structure makes tirzepatide suitable for controlled experimental investigations involving peptide characterization, receptor interactions, molecular signaling, and related biochemical pathways.